Clindamycin Hydrochloride and Sodium Chloride Injection
Indication
1. The product is suitable for the following infectious diseases caused by Gram-positive bacteria: 1) tonsillitis, suppurative otitis media, sinusitis, etc. 2) acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis combined infection, etc. 3) skin and soft tissue infection; furuncle, carbuncle, abscess, fossa tissue inflammation, trauma and postoperative infection, etc. 4) urinary system infection: acute urethritis, acute pyelonephritis, prostatitis, etc. 5) others: osteomyelitis, sepsis, peritonitis and oral infection, etc. 2. The product is suitable for various infectious diseases caused by anaerobic bacteria: 1) empyema, lung abscess, anaerobic lung disease. 2) skin and soft tissue infection, sepsis. 3) intra-abdominal infection: peritonitis, intra-abdominal abscess. 4) female pelvic and genital infection: endometritis, non-gonococcal fallopian tube and ovarian abscess, pelvic fossa tissue inflammation and post-gynecological surgery infection, etc.
Precautions
Patients with a history of allergy to clindamycin or lincomycin are contraindicated.
Packaging Specification
100ml: Clindamycin 0.3g and sodium chloride 0.9g
Manufacturer
Guangdong Litai Pharmaceutical Holdings Co., Ltd.
-
Founded in:
2003-01-13 -
Address:
Building 8, Industrial Zone, Dananshan Street, Puning City -
Tax NO.:
91445200728775458D -
Registered Funds:
395.20331 million yuan -
Website:
-
Email: